AdvanSix Inc. (NYSE:ASIX) on Friday reported a steep decline in third-quarter earnings, though revenue came in slightly ahead of Wall Street estimates.

The chemical manufacturer posted earnings of 8 cents per share, missing analysts’ average estimate of 40 cents, a decline from 88 cents per share a year earlier.

Quarterly sales fell 6% to $374.47 million, beating the consensus estimate of $365 million.

Also Read: Stanley Druckenmiller-Backed PureCycle Eyes $600M Payday

Adjusted EBITDA margin fell to 6.6% in the quarter, down from 13.4% a year earlier.

Cash flow from operations totaled $26.59 million for the quarter, down by $30.66 million from a year earlier, primarily reflecting lower net income.

Capital expenditures were $26.5 million, a decrease of $4.0 million from the prior-year period.

The company’s board declared a quarterly cash dividend ...